Teva launches generic Yaz

JERUSALEM Teva Pharmaceutical Industries has launched a generic oral contraceptive, the drug maker said Tuesday.

Gianvi is the generic version of Bayer's Yaz tablets, which had total sales of nearly $782 million in the United States for 12 months ended Dec. 31. Teva has been awarded a 180-day period of marketing exclusivity for the contraceptive.

As previously announced, Teva has the right to launch an authorized generic version of the product, supplied by Bayer, in July 2011.

Login or Register to post a comment.